Skip to content
Catholic Online Logo

By Catholic Online (NEWS CONSORTIUM)

4/6/2014 (4 months ago)

Catholic Online (www.catholic.org)

Drug cut in half the risk that cancer would worsen

An important treatment option in the fight against breast cancer may be waiting in the wings. Researchers say a new type of drug could help prevent advanced breast cancer from worsening. The potential is great for breast cancer patients, and makes for a potential blockbuster product for Pfizer.

While Pfizer remains in the lead to bring this new class of drugs to market, Novartis has begun late-stage testing of its own CDK 4/6 inhibitor.

While Pfizer remains in the lead to bring this new class of drugs to market, Novartis has begun late-stage testing of its own CDK 4/6 inhibitor.

Highlights

By Catholic Online (NEWS CONSORTIUM)

Catholic Online (www.catholic.org)

4/6/2014 (4 months ago)

Published in Health

Keywords: Pfizer, breast cancer, palbociclib


LOS ANGELES, CA (Catholic Online) - Said drug cut in half the risk that cancer would worsen, or progress, researchers said. The median time before the disease progressed or the women died was 20.2 months for those who received the drug, compared with 10.2 months for the control group.

"The magnitude of benefit we are seeing is not something commonly seen in cancer medicine studies," Dr. Richard S. Finn, a principal investigator in the study, says. Finn, an oncologist at the University of California, Los Angeles, called the results "quite groundbreaking."

No child need ever go to bed hungry -- Learn how you can help!


Known as palbociclib, the drug also appeared to prolong survival but not by a statistically significant amount. Those who received the drug lived a median of 37.5 months in contrast with 33.3 months for those in the control group.

The results from the Phase 2, or mid-stage, study were presented here at the annual meeting of the American Association for Cancer Research. Palbociclib is considered a jewel in Pfizer's product pipeline, with analysts predicting annual sales of billions of dollars. Amgen is entitled to an eight percent royalty on sales of the drug.

Some investors may have been letdown due to the drug, partly because they were not quite as good as interim results presented about halfway through the trial. At that point, the difference in median progression-free survival was 26.1 months for palbociclib versus 7.5 months for the control group.

Finn stresses that a statistically significant survival benefit should not have been expected at this point because only 61 of the 165 patients in the trial had died. Patients can use other drugs after leaving the trial, which can dilute any effect of palbociclib.

Palbociclib slows the proliferation of cancer cells by inhibiting the activity of two related enzymes involved in cell division; cyclin-dependent kinases 4 and 6.

While Pfizer remains in the lead to bring this new class of drugs to market, Novartis has begun late-stage testing of its own CDK 4/6 inhibitor. While breast cancer is the initial focus, the drugs are being tested for other cancers.

Breast cancer specialists not involved in the study were encouraged -- but expressed caution. "These results are strikingly positive and with a large potential impact to patients," Dr. José Baselga said in a speech at the conference discussing the results.

Baselga, the physician in chief at the Memorial Sloan-Kettering Cancer Center, also said the results might have been biased because the study investigators, who determined whether tumors had progressed, knew which patients were getting palbociclib.

Dr. Eric P. Winer, chief of women's cancers at the Dana-Farber Cancer Institute in Boston, says larger studies were still needed.

"This is a small Phase 2 trial - not tiny, but not the kind of study that would typically lead to a change in practice," he said.

---


Pope Francis: end world hunger through 'Prayer and Action'


© 2014 - Distributed by THE NEWS CONSORTIUM

Pope Francis Prayer Intentions for August 2014
Refugees:
That refugees, forced by violence to abandon their homes, may find a generous welcome and the protection of their rights.
Oceania: That Christians in Oceania may joyfully announce the faith to all the people of that region.



Comments


More Health

Electric shocks to the brain can aid those who suffer from stroke, Alzheimer's, memory loss Watch

Image of Previously, TMS has been used in a limited way to temporarily change brain function to improve performance during a test. The new study shows that TMS can be used to improve memory for events at least 24 hours after the stimulation is given.

By Catholic Online (NEWS CONSORTIUM)

Applying electric shocks to the brain can improve memory, researchers have found. Furthermore, researchers say the discovery could develop exciting new approaches for treating strokes, early-stage Alzheimer's and aging on the brain. LOS ANGELES, CA (Catholic ... continue reading


Do you eat pomegranates? Well here's a few reasons why you should Watch

Image of Pomegranates contain the chemical punicalagin, a form of a chemical compound known as polyphenol, which may help to prevent the inflammation that destroys brain cells known as micrologia.

By Catholic Online (NEWS CONSORTIUM)

An ingredient in pomegranate may help stop the spread of Alzheimer's disease, scientists from the University of Huddersfield claim. LOS ANGELES, CA (Catholic Online) - The chemical punicalagin, a form of a chemical compound known as polyphenol, helps prevent the ... continue reading


NEW HOPE IN EBOLA CRISIS: U.S. doctor released from hospital - cured Watch

Image of

By Catholic Online (NEWS CONSORTIUM)

Contracting the deadly African virus while he worked to save their lives, Dr. Kent Brantly became one of the handful of people from the United States to contract Ebola. Receiving treatment back in the U.S., Brantly walked out of the hospital to the waiting arms ... continue reading


HEALTH DISASTER: Is nearly half of all Americans destined to contract diabetes? Watch

Image of The irony of the situation is that Americans are generally living longer, which is a factor in their increased lifetime chance of developing type 2 diabetes. Americans are also not dying in the same proportions that they were, because of better treatment.

By Catholic Online (NEWS CONSORTIUM)

Has the United States reached the tipping point with diabetes and obesity? A shocking new study claims that nearly HALF of all Americans, if trends continue, will develop type 2 diabetes in the near future. Public Health England, in their most recent report ... continue reading


First large-scale shipment of new malaria drug shipped out Watch

Image of The recent shipment marks a new phase in the fight against the mosquito-borne disease.

By Catholic Online (NEWS CONSORTIUM)

Just as virulent - as far more easily transmitted than Ebola, malaria is making new inroads to populations in sub-Saharan Africa. In response, French drug maker Sanofi has announced the delivery of large-scale batches of an antimalarial drug made using ... continue reading


Very accurate colon cancer in-home detection kit approved by FDA Watch

Image of  The U.S. Food and Drug Administration has approved a new at-home, DNA-based stool test that screens for colorectal cancer with more than 90 percent accuracy.

By Catholic Online (NEWS CONSORTIUM)

Screening for colon cancer is frequently arduous and invasive. Patients need to fast prior to a colonoscopy, and the colonoscopy itself be highly uncomfortable and not always accurate. There's now good news for those at risk. The U.S. Food and Drug ... continue reading


You'll think twice before you put this dangerous chemical back in your mouth! Watch

Image of Colgate's Total brand of toothpaste contains the chemical triclosan, which has been proven to cause disruptions in the endocrine system in mice and rats.

By Catholic Online (NEWS CONSORTIUM)

A top-selling toothpaste uses the chemical triclosan which has been linked to cancer-cell growth and disrupted development in animals, and regulators are still reviewing whether or not it's safe to pt in soap, cutting boars and toys, while many consumer companies ... continue reading


New diabetes drug could help us all: Found effective in preventing cancer Watch

Image of Scientists who studied more than 180,000 people found a

By Catholic Online (NEWS CONSORTIUM)

According to a new study, a drug widely prescribed to treat type 2 diabetes could help us all live longer. Said drug, metformin, which controls glucose levels, may also stave off cardiovascular disease and cancer, regardless if the person is diabetic. LOS ... continue reading


Mutated gene increases women's chance for breast cancer by threefold Watch

Image of Doctors also could recommend more aggressive surveillance for breast cancer, such as annual mammograms or MRI breast screening.

By Catholic Online (NEWS CONSORTIUM)

A new study has found that mutated versions of a gene called PALB2 can dramatically increase a woman's risk of breast cancer. Researchers say that women carrying the PALB2 mutation have a one in three chance of developing breast cancer by the age of 70. LOS ... continue reading


WAS WORLD'S THROAT CUT? Ebola vaccine research was earlier abandoned Watch

Image of It must also be noted that while the National Institutes of Health and the U.S. government often fund the early animal safety and efficacy testing of a vaccine, pharmaceutical companies typically fund the human clinical trials to take a drug or vaccine to market.

By Catholic Online (NEWS CONSORTIUM)

With increasing fears of the Ebola virus in West Africa and elsewhere, world governments are now frantically trying to contain the disease. What is not widely known is the fact that there had been work on finding a vaccine for Ebola four years ago, that was ... continue reading


All Health News

Newsletters

Newsletter Sign Up icon

Stay up to date with the latest news, information, and special offers

Daily Readings

Reading 1, First Corinthians 3:1-9
1 And so, brothers, I was not able to talk to you as ... Read More

Psalm, Psalms 33:12-13, 14-15, 20-21
12 How blessed the nation whose God is Yahweh, the ... Read More

Gospel, Luke 4:38-44
38 Leaving the synagogue he went to Simon's house. ... Read More

Saint of the Day

Saint of the Day for September 3rd, 2014 Image

Pope Saint Gregory the Great
September 3: St. Gregory, born at Rome about the year 540, was the son of ... Read More

Inform, Inspire & Ignite Logo

Find Catholic Online on Facebook and get updates right in your live feed.

Become a fan of Catholic Online on Facebook


Follow Catholic Online on Twitter and get News and Product updates.

Follow us on Twitter